Squamous cell carcinomas (including HNSCC, ESCC, and LSCC) are unique cancers, primarily driven by copy number gains and losses, rather than drivers with gain-of-function mutations such as KRAS and EGFR (2). This evidence concerns the gene KRAS and squamous cell carcinoma.